CD46 expression is also upregulated in malignancies like hepatocellular carcinoma, possibly to escape complement-dependent cytotoxicity, but it remains unknown whether sCD46 titres are correspondingly elevated [25]. The gene discussed is CD46; the disease is hepatocellular carcinoma.